SCHEMBL8686408

SCHEMBL8686408

CCOC(=O)c1cc2ccccc2n1CCc1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.68
KDM4E B2RXH2 1/20 0.68
CRHBP P24387 1/20 0.68
CRHR2 Q13324 1/20 0.68
NOD2 Q9HC29 5/20 0.67
NOD1 Q9Y239 5/20 0.67
MEN1 O00255 1/20 0.67
KMT2A Q03164 1/20 0.67
MAPT P10636 2/20 0.61
F10 P00742 2/20 0.60
TSHR P16473 3/20 0.60
SRC P12931 1/20 0.54
MTNR1A P48039 1/20 0.53
MTNR1B P49286 1/20 0.53
ALDH1A1 P00352 3/20 0.52
POLB P06746 2/20 0.52
ATM Q13315 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
CCR2 P41597 1/20 0.51
GLA P06280 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3962292 0.90 NOD2 (0.69) SMN1; SMN2KDM4ECRHBPCRHR2NOD2
SCHEMBL4798323 0.88 NOD2 (0.85) SMN1; SMN2KDM4ECRHBPCRHR2NOD2
SCHEMBL3963612 0.87 SMN1; SMN2 (0.59) SMN1; SMN2KDM4ECRHBPCRHR2NOD2
SCHEMBL6752352 0.86 KDM4E (0.71) SMN1; SMN2KDM4ECRHBPCRHR2NOD2
SCHEMBL1422759 0.86 MTNR1A (0.65) SMN1; SMN2KDM4ECRHBPCRHR2NOD2
SCHEMBL30489155 0.85 KDM4E (0.73) SMN1; SMN2KDM4ECRHBPCRHR2NOD2
SCHEMBL4215637 0.85 KDM4E (0.70) SMN1; SMN2KDM4ECRHBPCRHR2NOD2
SCHEMBL13742183 0.85 KDM4E (0.70) SMN1; SMN2KDM4ECRHBPCRHR2NOD2
SCHEMBL18322286 0.85 KDM4E (0.73) SMN1; SMN2KDM4ECRHBPCRHR2NOD2
SCHEMBL21822198 0.85 TSHR (0.53) SMN1; SMN2KDM4ECRHBPCRHR2NOD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5811439-A ANTIDIABETIC AGENTS; SIDE EFFECT REDUCTION; ANTILEPEMIC AGENTS SENGA PHARMACEUTICAL LABORATORY INC. (JP) 1998-09-22 US disclosed
EP-0780389-A1 Thiazolidinedione derivatives, process for their preparation and pharmaceutical compositions containing them TOBISHI PHARMACEUTICAL CO., LTD. (JP) 1997-06-25 EP disclosed